News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,712 Results
Type
Article (27729)
Company Profile (115)
Press Release (384864)
Multimedia
Podcasts (67)
Webinars (12)
Section
Business (102292)
Career Advice (547)
Deals (18053)
Drug Delivery (91)
Drug Development (38958)
Employer Resources (80)
FDA (10907)
Job Trends (10030)
News (176122)
Policy (20873)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2123)
Academic (2)
Accelerated approval (21)
Adcomms (16)
Allergies (95)
Alliances (28694)
ALS (88)
Alzheimer's disease (1113)
Antibody-drug conjugate (ADC) (149)
Approvals (11218)
Artificial intelligence (365)
Autoimmune disease (85)
Automation (20)
Bankruptcy (148)
Best Places to Work (9004)
BIOSECURE Act (8)
Biosimilars (157)
Biotechnology (58)
Bladder cancer (103)
Brain cancer (35)
Breast cancer (358)
Cancer (2555)
Cardiovascular disease (289)
Career advice (510)
Career pathing (14)
CAR-T (117)
CDC (51)
Cell therapy (367)
Cervical cancer (26)
Clinical research (34123)
Collaboration (1070)
Compensation (148)
Complete response letters (22)
COVID-19 (2305)
CRISPR (52)
C-suite (509)
Cystic fibrosis (88)
Data (3765)
Decentralized trials (2)
Denatured (21)
Depression (108)
Diabetes (342)
Diagnostics (5165)
Digital health (47)
Diversity (10)
Diversity, equity & inclusion (24)
Drug discovery (140)
Drug pricing (169)
Drug shortages (12)
Duchenne muscular dystrophy (128)
Earnings (36260)
Editorial (40)
Employer branding (8)
Employer resources (73)
Events (76265)
Executive appointments (662)
FDA (13081)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1042)
Gene editing (99)
Generative AI (34)
Gene therapy (289)
GLP-1 (593)
Government (4392)
Grass and pollen (6)
Guidances (284)
Healthcare (15090)
HIV (54)
Huntington's disease (18)
IgA nephropathy (49)
Immunology and inflammation (113)
Immuno-oncology (29)
Indications (75)
Infectious disease (2550)
Inflammatory bowel disease (124)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (114)
Interviews (59)
IPO (7790)
IRA (40)
Job creations (1414)
Job search strategy (452)
JPM (61)
Kidney cancer (4)
Labor market (39)
Layoffs (212)
Leadership (11)
Legal (3940)
Liver cancer (57)
Longevity (12)
Lung cancer (314)
Lymphoma (203)
Machine learning (20)
Management (30)
Manufacturing (411)
MASH (107)
Medical device (9630)
Medtech (9674)
Mergers & acquisitions (10946)
Metabolic disorders (854)
Multiple sclerosis (113)
NASH (10)
Neurodegenerative disease (186)
Neuropsychiatric disorders (62)
Neuroscience (1893)
Neurotech (1)
NextGen: Class of 2026 (4994)
Non-profit (3950)
Now hiring (13)
Obesity (394)
Opinion (159)
Ovarian cancer (81)
Pain (111)
Pancreatic cancer (90)
Parkinson's disease (158)
Partnered (21)
Patents (220)
Patient recruitment (283)
Peanut (32)
People (33700)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (10805)
Phase 2 (13412)
Phase 3 (12130)
Pipeline (3399)
Policy (242)
Postmarket research (1574)
Preclinical (3465)
Press Release (47)
Prostate cancer (145)
Psychedelics (39)
Radiopharmaceuticals (170)
Rare diseases (540)
Real estate (2876)
Recruiting (33)
Regulatory (15616)
Reports (25)
Research institute (1969)
Resumes & cover letters (40)
Rett syndrome (20)
RNA editing (6)
RSV (65)
Schizophrenia (108)
Series A (162)
Series B (136)
Service/supplier (4)
Sickle cell disease (73)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (28)
Startups (2117)
Stomach cancer (4)
Supply chain (71)
Tariffs (47)
The Weekly (45)
Vaccines (854)
Venture capital (68)
Weight loss (240)
Women's health (84)
Worklife (7)
Date
Today (86)
Last 7 days (385)
Last 30 days (1380)
Last 365 days (18740)
2026 (2081)
2025 (19045)
2024 (21775)
2023 (24260)
2022 (33688)
2021 (37126)
2020 (37572)
2019 (33255)
2018 (24881)
2017 (17714)
2016 (18865)
2015 (21436)
2014 (16066)
2013 (12735)
2012 (13474)
2011 (13917)
2010 (11937)
Location
Africa (531)
Alabama (35)
Alaska (6)
Arizona (186)
Arkansas (11)
Asia (22444)
Australia (3970)
California (6227)
Canada (2188)
China (617)
Colorado (308)
Connecticut (335)
Delaware (192)
Europe (50472)
Florida (993)
Georgia (262)
Hawaii (2)
Idaho (39)
Illinois (601)
India (56)
Indiana (454)
Iowa (13)
Japan (299)
Kansas (89)
Kentucky (27)
Louisiana (24)
Maine (79)
Maryland (951)
Massachusetts (4608)
Michigan (221)
Minnesota (401)
Mississippi (3)
Missouri (121)
Montana (18)
Nebraska (20)
Nevada (93)
New Hampshire (59)
New Jersey (2170)
New Mexico (12)
New York (1957)
North Carolina (971)
North Dakota (4)
Northern California (3114)
Ohio (219)
Oklahoma (13)
Oregon (28)
Pennsylvania (1442)
Puerto Rico (12)
Rhode Island (29)
South America (681)
South Carolina (34)
South Dakota (1)
Southern California (2358)
Tennessee (139)
Texas (947)
United States (24596)
Utah (265)
Virginia (144)
Washington D.C. (53)
Washington State (603)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
412,712 Results for "elligo health research.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
Barry Simms Named as Elligo Health Research’s Chief Operating Officer
Elligo Health Research®, the largest healthcare-enabling research organization, announced the addition of Barry Simms as Elligo’s Chief Operating Officer.
August 29, 2023
·
2 min read
Lone Star Bio
Elligo Health Research Announces Expansion of Study Marketplace With Syneos Health
Elligo Health Research®, the largest healthcare-enabling research organization, announced it is expanding its Study Marketplace platform with Syneos Health, a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success.
October 5, 2023
·
2 min read
Bio NC
Catawba Research Partners With Elligo Health Research® to Expand Access and Simplify Clinical Research Participation
Catawba Research announced a new partnership with Elligo Health Research, the largest healthcare-enabling research organization, that will expand access to clinical trials.
December 6, 2023
·
2 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Lone Star Bio
Elligo Health Research Supporting Clinical Research Sites With a Platform to Help Grow Study Pipeline
Elligo Health Research®, the largest healthcare-enabling research organization, launched an updated version of its IntElligo® Study Marketplace, a technology-enabled solution that supports research sites in building a strong study pipeline.
June 22, 2023
·
2 min read
Lone Star Bio
Elligo Health Research® Names Dawn Sauro as New Chief Operating Officer
Elligo Health Research announced that Dawn Sauro has been named as Elligo’s Chief Operating Officer to help further the company’s growth, efficiency, and mission of optimizing the intersection of healthcare and research through direct access to patients, new technology, and custom research practice management solutions.
January 5, 2023
·
2 min read
Press Releases
SiPhox Health Introduces a Smarter Way of Health Tracking From Home
February 3, 2026
·
1 min read
Press Releases
Optimi Health’s Psilocybin Capsules Selected for Medibank Insurance Program
Australia’s largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSD
October 6, 2025
·
5 min read
Press Releases
Sotera Health Appoints Richard Kyle to the Board of Directors
February 5, 2026
·
2 min read
1 of 41,272
Next
